Rajesh Kumar Rai, Professor, Department of Pathology, B.R.D. Medical College, Gorakhpur, Uttar Pradesh 273013, India. , Shaila Kumari Mitra1 , Rajesh Kumar Rai2 , Kiriti Kanaujiya3 , Manjari Rao4
Background: HER-2/neu is a gene localized on chromosome 17q21 which encodes a growth factor receptor like molecule with tyrosine kinase activity and is known to encode a transmembrane glycoprotein. Aim: To study the expression of HER2/neu in benign and malignant lesions of cervix. Material and Methods: The present study was conducted on 100 cases of resected cervical tissue specimen suspected to have neoplastic lesions and hysterectomy specimen already diagnosed as carcinoma on cytology for a period of 12 months (September 2018 to August 2019). Results: Majority of benign cases were negative for HER-2/neu except few cases and positivity was higher in malignant than premalignant. Positivity was also higher in adenocarcinoma as compared to squamous cell carcinoma. Conclusion: HER-2/neu serves as a biological marker to identify high risk subgroups and can be useful as target for new treatment modalities.
No records found.
| Received | Accepted | Published |
|---|---|---|
| N/A | N/A | N/A |
Sunday 12 July 2026, 13:53:18 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | N/A |
| Accepted | N/A |
| Published | N/A |